4.4 Article

Prevalence of myositis specific and associated antibodies in a cohort of patients affected by idiopathic NSIP and no hint of inflammatory myopathies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Successful treatment of rapid progressive interstitial lung disease in a case of anti-Zo antibody positive anti-synthetase syndrome

Yongxia Li et al.

Summary: Anti-Zo-positive ASS is a rare autoimmune disease characterized by severe and rapidly progressive ILD. Combination therapy of corticosteroids and tacrolimus may improve patient outcomes.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2023)

Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

Summary: This article provides updates on the guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. The recommendations are based on consensus and systematic reviews, aiming to provide evidence-based guidance for clinicians.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Rheumatology

Anti-Zo antibodies in Japanese myositis patients detected by a newly developed ELISA

Yoshinao Muro et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Article Rheumatology

Defining anti-synthetase syndrome: a systematic literature review

Giovanni Zanframundo et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2022)

Article Immunology

Different Multivariable Risk Factors for Rapid Progressive Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis and Anti-Synthetase Syndrome

Yu Zuo et al.

Summary: RP-ILD is more prevalent in MDA5(+)DM patients compared to ASS patients, with lower survival rates. Independent risk factors for RP-ILD in MDA5(+)DM patients include fever, lymphopenia, decreased T cell levels, elevated ALT, high LDH, hyper-ferritin, and elevated CEA, among others. In contrast, independent risk factors for RP-ILD in ASS patients are elevated CEA, CA125, and NSE.

FRONTIERS IN IMMUNOLOGY (2022)

Article Respiratory System

Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China

Xi Zhan et al.

Summary: Anti-synthetase syndrome (ASSD) associated with interstitial lung disease (ILD) is characterized by diverse clinical features and different ILD patterns based on distinct anti-ARS antibodies. Most patients show positive response to steroid therapy, while the PL-7 (+) group demonstrates a poorer treatment response.

BMC PULMONARY MEDICINE (2021)

Article Allergy

Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis

Tamara Vojinovic et al.

Summary: Interstitial lung disease (ILD) occurs in about one third of patients with idiopathic inflammatory myositis (IIM), predominantly affecting those with anti-synthetase syndrome. ILD patterns in IIM patients include non-specific interstitial pneumonia (NSIP), organizing pneumonia (OP), and usual interstitial pneumonia-like (UIP). ILD onset is associated with dyspnea and anti-Ro52 antibodies, with the latter predicting a significant improvement in DLCO during follow-up.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Article Medicine, General & Internal

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease

Sofia A. Moll et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Review Pharmacology & Pharmacy

Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome

Yongpeng Ge et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)

Review Medicine, General & Internal

Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment

Baptiste Hervier et al.

FRONTIERS IN MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome

Hui Liu et al.

EUROPEAN RADIOLOGY (2019)

Article Respiratory System

Prevalence of Myositis-Specific Antibodies in Idiopathic Interstitial Pneumonias

Laurens J. De Sadeleer et al.

Review Respiratory System

Idiopathic non-specific interstitial pneumonia

Elizabeth A. Belloli et al.

RESPIROLOGY (2016)

Article Respiratory System

Idiopathic inflammatory myopathies and the lung

Jean-Christophe Lega et al.

EUROPEAN RESPIRATORY REVIEW (2015)

Article Rheumatology

Interstitial Lung Disease in AntiJo-1 Patients With Antisynthetase Syndrome

I. Marie et al.

ARTHRITIS CARE & RESEARCH (2013)

Article Cardiac & Cardiovascular Systems

Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias

Kizuku Watanabe et al.

RESPIRATORY MEDICINE (2011)